Stoxline.com

Stock Symbol:   

Stoxline Mobile
Home  |  Stock Charts  |  Showcases  |  Stock Ranks  |  Options  |  ETFs  |  Educations  |  Forex Crypto

Biocept Inc. (BIOC)

4.69   0.33 (7.57%) 09-29 09:31
Open: 4.26 Pre. Close: 4.36
High: 4.69 Low: 4.5499
Volume: 327,455 Market Cap: 63M
Biocept, Inc. is an oncology laboratory service company, which focuses on the development and marketing of novel laboratory products in the detection of rare cells to include circulating tumor cells. The company is headquartered in San Diego, California and currently employs 42 full-time employees. The firm develops and commercializes circulating tumor cell (CTC) and circulating tumor deoxyribonucleic acid (ctDNA), assays utilizing a standard blood sample, or liquid biopsy. The firm's Target-Selector offering is based on an internally developed, microfluidics-based CTC capture and analysis platform, with enabling features that change how CTC testing can be used by clinicians by providing biomarker detection and monitoring requiring only a standard blood sample. The ctDNA technology enables mutation detection and is applicable to nucleic acid from CTCs or other sample types, such as blood plasma. The firm commercializes its Target-Selector assays for a range of solid tumor indications, such as breast cancer, non-small cell lung cancer (NSCLC), small cell lung cancer (SCLC), gastric cancer, colorectal cancer, prostate cancer and melanoma.

Stock Price Prediction

Update at 5:00pm EST
If tomorrow: Open lower Open higher
High: 4.295 - 4.316 4.316 - 4.337
Low: 4.04 - 4.065 4.065 - 4.091
Close: 4.152 - 4.193 4.193 - 4.234

Technical analysis

as of: 2020-09-28 4:30:21 PM
Overall:       
Stoxline posted a SELL today, downgraded from higher rating. Downward movement to be expected.
Target: Six months: 7.32     One year: 9.34
Support: Support1: 3.46    Support2: 2.88
Resistance: Resistance1: 6.27    Resistance2: 8.00
Pivot: 4.33
Moving Average: MA(5): 4.40     MA(20): 4.84
MA(100): 6.28     MA(250): 5.19
MACD: MACD(12,26): -0.76     Signal(9): -0.84
Stochastic oscillator: %K(14,3): 28.19     %D(3): 29.09
RSI: RSI(14): 36.45
52-week: High: 13.00  Low: 2.10  Change(%): -48.1
Average Vol(K): 3-Month: 177030  10-Days: 79608

Price, moving averages and Bollinger Bands

Price and moving averages has closed below its Short term moving average. Short term moving average is currently below mid-term; AND below long term moving averages. From the relationship between price and moving averages; we can see that: This stock is BEARISH in short-term; and NEUTRAL in mid-long term.
BIOC has closed above bottom band by 41.6%. Bollinger Bands are 49.5% narrower than normal. The narrow width of the bands suggests low volatility as compared to BIOC's normal range. The bands have been in this narrow range for 0 bars. This is a sign that the market may be about to initiate a new trend.

Headline News

Tue, 22 Sep 2020
Stocks In News: Today’s Market Movers Include Biocept, Inc. (BIOC) - investmillion.com

Mon, 21 Sep 2020
Is it Time to Dump Biocept Inc (BIOC) Stock After it Is Up 18.73% in a Week? - InvestorsObserver

Wed, 16 Sep 2020
Will Biocept Inc (BIOC) Beat the Rest of the Stocks in the Healthcare Sector? - InvestorsObserver

Mon, 14 Sep 2020
Biocept Inc. (BIOC) is set for a tempting yields with an average volume of 2.64M - The InvestChronicle

Fri, 11 Sep 2020
Should Biocept Inc (BIOC) be in Your Portfolio? - InvestorsObserver

Wed, 09 Sep 2020
Biocept to Present at the H.C. Wainwright Global Investment Virtual Conference on September 14 - WFMZ Allentown

Financial Analysis

Growth
Growth measures the growth of both a company's revenue and net income. it tells investors how fast a company is growing.
Profitability
Profitability measures a company’s ability to generate earnings as compared to its expenses and other relevant costs.
Solvency
Solvency measures a company's ability to meet its long-term debts. Acceptable solvency ratios will vary from industry to industry.
Efficiency
Efficiency measures the strength of a company's return on invested capital. It can identify business that are better managed or not.
Price to Book Value: Outperform Discounted cash flow: Outperform
Return on Assets: Underperform Price to Earnings: Underperform
Return on Equity: Underperform Debt to Equity: Neutral
Free Technical Analysis Charts

Stock Basics & Statistics

Exchange:  NASDAQ
Sector:  Healthcare
Industry:  Diagnostics & Research
Shares Out. (M) 134
Shares Float (M) 12
% Held by Insiders 0.03
% Held by Institutions 7.99
Shares Short (K) 318
Shares Short P. Month (K) 540

Stock Financials

EPS -4.112
EPS Est This Year
EPS Est Next Year
Book Value (p.s.) 1.990
Profit Margin
Operating Margin -420.94
Return on Assets (ttm) -56.4
Return on Equity (ttm) -133.9
Qtrly Rev. Growth -23.0
Gross Profit (p.s.) -0.041
Sales Per Share 0.042
EBITDA (p.s.) -0.171
Qtrly Earnings Growth
Operating Cash Flow (M) -23
Levered Free Cash Flow (M) -15

Stock Valuations

PE Ratio -1.02
PEG Ratio
Price to Book value 2.11
Price to Sales 99.03
Price to Cash Flow -24.40

Stock Dividends

Dividend
Forward Dividend
Dividend Yield
Dividend Pay Date Invalid DateTime.
Ex-Dividend Date Invalid DateTime.
7 Binary Options
Your Ad Here
android_stock_chart
Stock Chart
stoxline_lite
Stoxline Lite
stoxline_pro
Stoxline Pro
Option_Calculator
Option Calculator
(c) 2006-2020 Stoxline.com | Contact us           
Data and information is provided for informational purposes only, and is not intended for trading purposes. Neither Stoxline.com nor its data provider shall be liable for any errors or delays in the content, or for any actions taken in reliance thereon. By accessing the Stoxline.com web site, a user agrees not to redistribute the information found therein.